BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27289329)

  • 1. Optimization of the alkyl side chain length of fluorine-18-labeled 7α-alkyl-fluoroestradiol.
    Okamoto M; Shibayama H; Naka K; Kitagawa Y; Ishiwata K; Shimizu I; Toyohara J
    Nucl Med Biol; 2016 Aug; 43(8):512-9. PubMed ID: 27289329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
    Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
    Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and basic evaluation of 7α-(3-[
    Okamoto M; Naka K; Ishiwata K; Shimizu I; Toyohara J
    Ann Nucl Med; 2017 Jan; 31(1):53-62. PubMed ID: 27680022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals.
    Seimbille Y; Rousseau J; Bénard F; Morin C; Ali H; Avvakumov G; Hammond GL; van Lier JE
    Steroids; 2002 Aug; 67(9):765-75. PubMed ID: 12123788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of the Estrogen Receptor β-Selective Radioligand 2-
    Antunes IF; van Waarde A; Dierckx RA; de Vries EG; Hospers GA; de Vries EF
    J Nucl Med; 2017 Apr; 58(4):554-559. PubMed ID: 27908969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.
    Bénard F; Ahmed N; Beauregard JM; Rousseau J; Aliaga A; Dubuc C; Croteau E; van Lier JE
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1473-9. PubMed ID: 18360749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
    Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ
    J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
    Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
    VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
    J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of brain estrogen receptors in rats: a 16α-18F-fluoro-17β-estradiol PET study.
    Khayum MA; de Vries EF; Glaudemans AW; Dierckx RA; Doorduin J
    J Nucl Med; 2014 Mar; 55(3):481-7. PubMed ID: 24481026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780).
    Seimbille Y; Bénard F; Rousseau J; Pepin E; Aliaga A; Tessier G; van Lier JE
    Nucl Med Biol; 2004 Aug; 31(6):691-8. PubMed ID: 15246359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
    Paquette M; Ouellet R; Archambault M; Croteau É; Lecomte R; Bénard F
    Nucl Med Biol; 2012 Jan; 39(1):57-64. PubMed ID: 22079037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can fluorine-18 fluoroestradiol positron emission tomography-computed tomography demonstrate the heterogeneity of breast cancer in vivo?
    Yang Z; Sun Y; Zhang Y; Xue J; Wang M; Shi W; Zhu B; Hu S; Yao Z; Pan H; Zhang Y
    Clin Breast Cancer; 2013 Oct; 13(5):359-63. PubMed ID: 23787040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity.
    Pomper MG; VanBrocklin H; Thieme AM; Thomas RD; Kiesewetter DO; Carlson KE; Mathias CJ; Welch MJ; Katzenellenbogen JA
    J Med Chem; 1990 Dec; 33(12):3143-55. PubMed ID: 1701833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and breast tumor uptake of 16alpha-[18F]-fluoro-17beta-estradiol in rat.
    Sasaki M; Fukumura T; Kuwabara Y; Yoshida T; Nakagawa M; Ichiya Y; Masuda K
    Ann Nucl Med; 2000 Apr; 14(2):127-30. PubMed ID: 10830531
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kumar M; Salem K; Michel C; Jeffery JJ; Yan Y; Fowler AM
    J Nucl Med; 2019 Sep; 60(9):1247-1252. PubMed ID: 30850489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
    Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R
    Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
    Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
    Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.
    van Kruchten M; de Vries EF; Arts HJ; Jager NM; Bongaerts AH; Glaudemans AW; Hollema H; de Vries EG; Hospers GA; Reyners AK
    J Nucl Med; 2015 Jan; 56(1):50-5. PubMed ID: 25476534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titration of the in vivo uptake of 16 alpha-[18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development.
    Katzenellenbogen JA; Mathias CJ; VanBrocklin HF; Brodack JW; Welch MJ
    Nucl Med Biol; 1993 Aug; 20(6):735-45. PubMed ID: 8401374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.